Edition:
United States

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

8.06USD
24 Feb 2017
Change (% chg)

$0.03 (+0.37%)
Prev Close
$8.03
Open
$7.94
Day's High
$8.14
Day's Low
$7.94
Volume
63,990
Avg. Vol
92,339
52-wk High
$9.87
52-wk Low
$5.90

NEO.OQ

Chart for NEO.OQ

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. Its Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The Company offers testing services, which includes... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $632.81
Shares Outstanding(Mil.): 78.51
Dividend: --
Yield (%): --

Financials

  NEO.OQ Industry Sector
P/E (TTM): -- 31.89 29.63
EPS (TTM): -0.24 -- --
ROI: -0.50 5.57 12.96
ROE: -13.55 8.86 14.11

BRIEF-NeoGenomics Q4 GAAP loss per share $0.18

* NeoGenomics reports 122% revenue growth to $60.5 million and 11% reduction in average cost per test in the fourth quarter of 2016

Feb 22 2017

BRIEF-Neogenomics reports 142% revenue growth to $60.8 million and $9.6 million in cash flow from operations in the third quarter of 2016

* Neogenomics reports 142% revenue growth to $60.8 million and a record $9.6 million in cash flow from operations in the third quarter of 2016

Oct 26 2016

More From Around the Web

Earnings vs. Estimates